A 7-month-old unvaccinated domestic shorthair cat was presented with a history of inappetence and hypersalivation. Clinical examination revealed fever, gingivitis and oral ulceration. An initial blood sample revealed a severe leukopenia and neutropenia and a feline panleukopenia virus (FPV) titre of 1:640; a second titre 10 days later was 1:2,560. A feline calicivirus (FCV) titre was 1:320 and the initial clinical signs and laboratory findings were attributed to a coinfection with FPV and FCV. The cat was treated with interferon omega. A blood sample taken 10 days later revealed a severe thrombocytosis of 3,448 × 10/L (reference range 200-500 × 10/L) confirmed by blood smear examination. The platelet count on day 35 was 4,990 × 10/L. No bone marrow examination was carried out. Two differential diagnoses for an extreme thrombocytosis are a reactive thrombocytosis or essential thrombocythemia (ET). ET is a hemic neoplasia that causes a severe and persistent thrombocytosis, and is a diagnosis of exclusion. Reactive thrombocytosis is generally mild to moderate and of shorter duration than described here, but an excessive response could have been caused by infection. The influence of additional factors such as an initial thrombocytopenia, age and interferon treatment are not clear but can be speculated on. Although the exact pathophysiology in this case remains unclear, such high, persistent thrombocyte numbers have not been reported in cats in the absence of a neoplastic process.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087589 | PMC |
http://dx.doi.org/10.1007/s00580-010-1036-z | DOI Listing |
Cureus
December 2024
Academic Affairs and Research, Orlando Regional Medical Center, Orlando, USA.
Essential thrombocythemia (ET) is a type of myeloproliferative neoplasm (MPN) disorder characterized by persistent thrombocytosis and characterized by frequent association with cellular genetic alterations. The 10%-15% of ET that is not associated with genetic abnormalities is known as triple-negative essential thrombocythemia (TNET). A common complication observed in around 20% of ET patients is the development of acquired von Willebrand disease (AvWD).
View Article and Find Full Text PDFJ Blood Med
December 2024
Department of Hematology, Hamad Medical Corporation, Doha, Qatar.
IDCases
November 2024
Department of Pathology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, United States.
is an opportunistic bacterium that is often identified in asymptomatic, healthy individuals from colonization of the genitourinary tract. However, in immunocompromised patients with hypogammaglobulinemia, has been reported to cause a wide range of infections, most commonly urethritis and cystitis. The absence of a bacterial cell wall prevents from being cultured using routine bacteriologic media and makes it resistant to commonly prescribed antibiotics.
View Article and Find Full Text PDFJAMA
January 2025
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Pediatr Blood Cancer
December 2024
Department of Pediatrics, The Children's Hospital of The King's Daughters, Norfolk, Virginia, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!